Publicacións en colaboración con investigadores/as de Hospital Vall d'Hebron (3)

2025

  1. PET biodistribution study of subcutaneous and intravenous administration of adalimumab in an inflammatory bowel disease model

    International Journal of Pharmaceutics, Vol. 669

2024

  1. Preclinical characterization of endotoxin-induced uveitis models using OCT, PET/CT and proteomics

    International Journal of Pharmaceutics, Vol. 662

2023

  1. Efficacy and safety of a new medicated nail hydrolacquer in the treatment of adults with toenail onychomycosis: A randomised clinical trial

    Mycoses, Vol. 66, Núm. 7, pp. 566-575